GeneralConnection.com ➔ Dictionary
Dictionary Search

savara

Synonyms

Noun

1. Savara

2. Dravidian, Savara

3. South-Central Dravidian

Usage
Does FDA Review of MOLBREEVI and Insider Sales Shift the Bull Case For Savara (SVRA)? - simplywall.st
What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline - The Motley Fool
What Does the FDA's Priority Review Mean for Savara's MOLBREEVI - Kavout | AI
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Savara Inc. (SVRA) Investors of November 7, 2025 Deadline - The National Law Review
SVRA Forecast — Price Target — Prediction for 2027 - TradingView
Savara Announces Chief Financial and Administrative Officer Transition - Business Wire
Assessing Savara (SVRA) Valuation As Shares Cool After Strong Long Term Returns - Yahoo Finance
FDA Extends Review of Savara’s Molgramostim BLA for PAP - BioPharm International
Savara (SVRA) CFO exercises 580K options and sells 394K shares in Form 4 - Stock Titan
Is Savara (SVRA) Expensive As Its Rally Puts A Premium On Book Value? - simplywall.st
FDA delays decision on Savara’s rare lung disease therapy to November - FirstWord Pharma
Savara, Inc. Actuals & Estimates (FWB:YB4P) - TradingView
Savara Announces New Employment Inducement Grant - Business Wire
Savara Inc. (SVRA) Reports Q1 Financial Results - Yahoo Finance
Savara Reports First Quarter Financial Results and Provides Business Update - Business Wire
Savara (SVRA) Stock Valuation After CFO Transition And Leadership Change - simplywall.st
Does Savara’s Expanded Share Pool and CFO Shift Reframe Its Capital Strategy Narrative (SVRA)? - simplywall.st
Savara Announces Participation in 2026 Citizens Life Sciences Conference - Business Wire
Savara To Present New Data at the American Thoracic Society (ATS) 2026 International Conference - Business Wire
Savara (SVRA) expands share capacity and appoints Robert Lutz as CFO/COO - Stock Titan
Savara (SVRA) Is Down 8.0% After FDA Grants Priority Review To MOLBREEVI - What's Changed - Yahoo Finance
Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update - Business Wire
Savara Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) for MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Yahoo Finance
Savara: The Rare Disease Funnel Is Becoming A Commercial Asset (NASDAQ:SVRA) - Seeking Alpha
Action Roguelite Savara Released on Consoles - RPGamer
Savara Announces the U.S. Food & Drug Administration (FDA) Has Extended the Review Period for the Molgramostim Inhalation Solution (Molgramostim) Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - BioSpace
A Look At Hercules Capital (HTGC) Valuation After The Expanded Savara Loan Agreement - Yahoo Finance
Savara Announces New Exercise Capacity Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - BioSpace
Savara Is On Xbox And PlayStation – And It Wants You To Earn Every Victory - TheXboxHub
Savara: Lowrance Will Remain Available in Advisory Capacity >SVRA - Moomoo
Savara Announces Chief Financial And Administrative Officer Transition - TradingView
Savara’s FDA Review Extension Keeps Molgramostim Thesis Intact But Delayed - simplywall.st
Savara Hanft - FloWrestling
Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants - Business Wire
Savara, the colorful action roguelite launches Today on PlayStation 5 and Xbox Series X|S - Games Press
Savara shareholders approve share increases and executive changes at annual meeting - Investing.com
Savara CFO David Lowrance sells $2.24m in company stock By Investing.com - Investing.com Nigeria
Form 4 Savara Inc For: 22 June By Investing.com - Investing.com Nigeria
Savara gives 24 new hires stock awards tied to tenure and revenue - Stock Titan
Savara CFO Dave Lowrance to step down, Robert Lutz to expand role - Investing.com
Savara Stock: A High-Risk Opportunity (NASDAQ:SVRA) - Seeking Alpha
Battle For the Gods in Rogue-lite Savara, Coming to Consoles in May - Hey Poor Player
Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Business Wire
Savara Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $149.5M - Business Wire
Roguelite action game Savara coming to PS5, Xbox Series on May 20 - Gematsu
Rare lung disease trial: Savara drug cuts biomarkers tied to severity - Stock Titan
Savara Reports First Quarter Financial Results and Provides Business Update - BioSpace
Savara Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView
Savara Presented Long-Term Efficacy and Safety Data from the Ongoing IMPALA-2 Phase 3 Clinical Trial Open-Label (OL) Extension of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - Yahoo Finance
Savara Has Finally Arrived on PlayStation 5 and Xbox Series X/S Today - COGconnected
Savara (SVRA) Announces Leadership Changes in Finance Department - GuruFocus
Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - BioSpace
Oppenheimer Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Savara (SVRA) deepens Q1 2026 loss while pushing MOLBREEVI toward key FDA and EMA decisions - Stock Titan
Form 144 Savara Inc For: 22 June By Investing.com - Investing.com Nigeria
Form 4 Savara Inc For: 22 June By Investing.com - Investing.com South Africa
Savara CFO David Lowrance sells $2.24m in company stock By Investing.com - Investing.com South Africa
Form 4 Savara Inc For: 22 June By Investing.com - Investing.com Canada
Rare lung disease with no drugs: regulators review new MOLBREEVI therapy - Stock Titan
Savara CFO David Lowrance sells $2.24m in company stock - Investing.com UK
Savara CFO Dave Lowrance steps down; COO Robert Lutz takes on CFO role amid leadership reshuffle - Pluang
Savara CFO David Lowrance sells $2.24m in company stock By Investing.com - Investing.com Canada
Savara Promotes Dr. Yasmine Wasfi to Chief Medical Officer - Contract Pharma
Savara Review (PS5) – Savara’Faire - fingerguns.net
Savara CFO David Lowrance sells $2.24m in company stock By Investing.com - Investing.com Australia
Form 4 Savara Inc For: 22 June By Investing.com - Investing.com UK
Savara - Launch Trailer (PS5) - Gamereactor UK
Langhorne, PA Biotech Eyes Mid-2026 Molbreevi Launch - Streetwise Reports
Savara Inc. Sees Price Target Raised Amid Promising Drug Developments - StocksToTrade
Savara CFO David Lowrance sells $2.24m in company stock By Investing.com - Investing.com India
Form 144 Savara Inc For: 22 June By Investing.com - Investing.com Canada
Form 144 Savara Inc For: 22 June By Investing.com - Investing.com Australia
Form 144 Savara Inc For: 22 June By Investing.com - Investing.com UK
Savara resubmits FDA application for potential treatment in rare lung disease patients - Indian Pharma Post
Savara - Farova Forever (Official Visualizer) - YouTube
Shareholders of Savara Inc. (SVRA): Protect Your Rights Before November 7, 2025 - Contact Levi & Korsinsky - The National Law Review
Class Action Lawsuit Filed: Savara Inc. (SVRA) - Join by November 7, 2025 - Contact Levi & Korsinsky - The National Law Review
What Is Driving Attention Toward Savara’s Rare Disease Strategy? - Kalkine Media
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
Form 144 Savara Inc For: 22 June By Investing.com - Investing.com India
Dumper rams BJP MP Hemant Savara’s car near Mumbai; driver suffers fracture - The Times of India
Savara upgraded at H.C. Wainwright on potential refiling of marketing application - MSN
Savara Stock Surges Amid Positive Financial Developments and Raised Price Target - timothysykes.com
Bragar Eagel & Squire, P.C. Reminds Investors of Tronox, - GlobeNewswire
Savara - Official Launch Trailer - IGN India
Form 4 Savara Inc For: 22 June By Investing.com - Investing.com India
Savara Promotes Yasmine Wasfi, M.D., Ph.D., FCCP To CMO - citybiz
Savara Inc (SVRA) Institutional Confidence - TradingKey
Savara Inc (SVRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Savara gets FDA review extension for lead asset - MSN
Savara Inc (SVRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Investors Urged to Contact Levi & Korsinsky for Information Before November 7, 2025 - Savara Inc. (SVRA) - The National Law Review
November 7, 2025 Deadline Approaching: Join Class Action Against Savara Inc. (SVRA) - Contact Levi & Korsinsky - The National Law Review
Savara steps into Grammy spotlight with consideration in two categories - Citizen Digital
SVRA Stock Slips Post-Market After FDA Delays Decision On Pulmonary Therapy - Stocktwits
SVRA Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Advances Pipeline - Earnings Season Preview - dars.gov.et
FDA calls for additional manufacturing data in refusal letter for Savara's respiratory asset - Fierce Pharma
Savara Stock - Long-term pipeline story in rare lung disease - AD HOC NEWS
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital - Business Wire
Manufacturing issues scupper Savara's lead drug filing - pharmaphorum
Foreign Language Equivalents
Foreign Language Equivalents of 'savara'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
ssvara,   svara,   svaara,   savars,   ssavara,   savarra,   savaar,   saara,   savaara,   asvara,   savra,   savaea,   savvara,   savata,   savar,   savaa,   savaraa,   aavara,   savraa,   sabara,   sacara,   avara,   davara,   saavra,   saavara,   savsra
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z